Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
April 25, 2022 at 10:48 am EDT
Share
Guangdong Biolight Meditech Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 1,074.28 million compared to CNY 1,385.63 million a year ago. Revenue was CNY 1,091.02 million compared to CNY 1,396.01 million a year ago. Net income was CNY 63.79 million compared to CNY 346.15 million a year ago. Basic earnings per share from continuing operations was CNY 0.4367 compared to CNY 2.3694 a year ago. Diluted earnings per share from continuing operations was CNY 0.4367 compared to CNY 2.3632 a year ago.
GUANGDONG BIOLIGHT MEDITECH CO., LTD. is a China-based company principally engaged in the research, development, production and sales of medical monitoring equipment, hemodialysis products and ancillary products. Its medical monitoring equipment includes monitoring equipment, electrocardiograph, pulse oximeters and central monitoring systems. Its hemodialysis products include hemodialysis machines, hemodialyzers, hemodialysis powders/dialysates and perfusion machines. The Company distributes its products in domestic and overseas markets.